4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-16-091700
CIK 0001373707operating
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 4:16 PM ET
Size
8.0 KB
Accession
0001209191-16-091700
Insider Transaction Report
Form 4
Watt Christopher
VP, Finance
Transactions
- Award
Employee Stock Option (right to buy)
2016-01-06+25,000→ 25,000 totalExercise: $8.47Exp: 2026-01-05→ Common Stock (25,000 underlying) - Award
Restricted Stock Units
2016-01-06+12,500→ 12,500 totalExercise: $0.00→ Common Stock (12,500 underlying)
Footnotes (3)
- [F1]Vests as to 6.25% of the shares on 4/6/2016 and further vests as to an additional 6.25% of the original grant at the end of each successive three-month period thereafter until 1/6/2020.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock of Tetraphase Pharmaceuticals, Inc. for no consideration.
- [F3]The restricted stock units vest in three equal installments on each of January 6, 2017, January 6, 2018 and January 6, 2019.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 4:16 PM ET
- Size
- 8.0 KB